Perceptive Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Perceptive Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-83,893	Closed	-$582K	–	204
2016 Q4	$582K	Buy	83,893 +16,780	+25%	+$107K	0.04%	108
2016 Q3	$342K	Hold	67,113	–	–	0.02%	147
2016 Q2	$401K	Buy	+67,113	New	+$372K	0.03%	133
2014 Q2	–	Sell	-380,000	Closed	-$1.58M	–	144
2014 Q1	$1.58M	Buy	+380,000	New	+$1.3M	0.17%	81

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's ENZ Position: Q1 2017 in Review

Perceptive Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q1 2017, closing a stake of 83,893 shares — an estimated $582K sold.

Perceptive Advisors first reported a position in ENZ in Q1 2014 and held it in 4 quarters. The position peaked at $1.58M in Q1 2014. 109 funds tracked by Wall St. Rank hold ENZ as of Q1 2017.

Perceptive Advisors reported no remaining Enzo Biochem, Inc. position as of Q1 2017 after selling out during the quarter.
Perceptive Advisors sold 83,893 Enzo Biochem, Inc. shares in Q1 2017, an estimated $582K.
Perceptive Advisors first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 4 quarters.
Perceptive Advisors's Enzo Biochem, Inc. position peaked at $1.58M in Q1 2014.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.